Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mattie

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusionJ Berkhout, L G Visser, P J van den Broek, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonamM L van Ogtrop, H F Guiot, H Mattie, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1991
Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivoM L van Ogtrop, H Mattie, H F Guiot, et al.
British Journal of Clinical Pharmacology|August 10, 2000
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosisB J Angus, M D Smith, Y Suputtamongkol, et al.
British Journal of Clinical Pharmacology|May 3, 2000
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosisB J Angus, M D Smith, Y Suputtamongkol, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1990
Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivoM L van Ogtrop, H Mattie, H F Guiot, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritisB E van den Borne, R B Landewé, H S Goei The, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusionJ Berkhout, L G Visser, P J van den Broek, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonamM L van Ogtrop, H F Guiot, H Mattie, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1991
Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivoM L van Ogtrop, H Mattie, H F Guiot, et al.
British Journal of Clinical Pharmacology|August 10, 2000
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosisB J Angus, M D Smith, Y Suputtamongkol, et al.
British Journal of Clinical Pharmacology|May 3, 2000
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosisB J Angus, M D Smith, Y Suputtamongkol, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1990
Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivoM L van Ogtrop, H Mattie, H F Guiot, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritisB E van den Borne, R B Landewé, H S Goei The, et al.
Pageof 11